Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
High risk NBL is defined based on the patient's age (> 18 months), disease metastasis, tumor histology, and MYCN gene amplification.
Abbas & Samkari 2022 Current Cancer Therapy Reviews 18: 14-40
High risk NBL is diagnosed in nearly 40% of patients, mainly those > 18 months of age, and is associated with aggressive clinical behavior.
Abbas & Samkari 2022 Current Cancer Therapy Reviews 18: 14-40
High risk NBL carries a high mortality rate accounting for nearly 15% of pediatric cancer deaths.
Abbas & Samkari 2022 Current Cancer Therapy Reviews 18: 14-40
However, most mortalities are attributed to the high frequency of disease relapse (50%) and disease reactiveness to therapy (20%).
Abbas & Samkari 2022 Current Cancer Therapy Reviews 18: 14-40…